According to the company’s announcement on Friday, Pricol Ltd. reported a combined profit of Rs. 47.52 crore for the quarter ending in September 2022.
In the same quarter of the prior year, the city-based automotive technology company reported a combined profit of $14.66 crore.
According to the corporation, the consolidated profit for the six-month period ending September 30, 2022, increased from the 20.60 crores recorded in the same period of the previous year to 68.12 crores.
In comparison to the same period previous year, the consolidated total income increased to 516.46 crore during the quarter under review from 409.49 crore.
After US inflation statistics came in lower than anticipated, the Indian rupee appreciated while the dollar fell, fueling hopes that the Federal Reserve might reconsider its hawkish position on monetary policy. In comparison to its previous close of 81.80, the rupee increased to a two-month high of 80.80 per dollar. According to Reuters, this is also the rupee’s largest intraday percentage gain since December 2018.
Following a decline in US peers, Indian government bond yields fell on Friday, with the benchmark yield reaching a more-than-seven-week low.
Following the arrest of one of its directors by the Enforcement Directorate, shares of Aurobindo Pharma fell to a 52-week low the previous day, but they increased by about 3% in early trading on Friday.
The stock increased from its starting price of 481.50 to 492.10 on the BSE. The price reached a day high of $496.95.
After one of its directors, P Sarath Chandra Reddy, was detained by the Enforcement Directorate in connection with the Delhi Excise Policy Case on Thursday, it reached a 52-week low of $464.20.
On Thursday, the scrip had reached its BSE closing price of 481.50.
On Friday morning, the company’s shares were trading in the green on both the BSE and NSE, regaining lost territory.